Share ownership GSK plc

GSK

GB00BN7SWP63

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 08:38:23 13/05/2026 BST			5-day change	1st Jan Change
1,889.00 ^GBX	-0.13%		+0.67%	+3.45%

05-12	European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading	MT
05-11	Global markets live: Alphabet, Cerebras, Compass, GSK, Rockwool…

Share class: GSK plc

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	4,316,204,889	3,984,154,700 ( 92.31 %)	261,378,286 ( 6.056 %)	92.31 %

Major shareholders: GSK plc

Name	Equities	%	Valuation
Dodge & Cox 2.194 %	88,958,040	2.194 %	2 331 M p
BlackRock Investment Management (UK) Ltd. 1.778 %	72,082,936	1.778 %	1 889 M p
Schroder Investment Management Ltd. 1.726 %	69,968,630	1.726 %	1 834 M p
Norges Bank Investment Management 1.562 %	63,324,000	1.562 %	1 659 M p
Wellington Management Co. LLP 1.55 %	62,865,245	1.55 %	1 647 M p
BlackRock Advisors (UK) Ltd. 1.503 %	60,932,357	1.503 %	1 597 M p
Legal & General Investment Management Ltd. 1.309 %	53,062,905	1.309 %	1 391 M p
SSgA Funds Management, Inc. 1.269 %	51,447,142	1.269 %	1 348 M p
BlackRock Fund Advisors 1.219 %	49,446,002	1.219 %	1 296 M p
Vanguard Asset Management Ltd. 1.204 %	48,840,000	1.204 %	1 280 M p
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Dodge & Cox 3.38 %	68,517,969	3.38 %	3 584 M p
Fidelity Management & Research Co. LLC 3.328 %	67,469,409	3.328 %	3 529 M p
Dodge & Cox 2.746 %	55,669,429	2.746 %	2 912 M p
Fisher Asset Management LLC 1.703 %	34,522,363	1.703 %	1 806 M p
PRIMECAP Management Co. 1.243 %	25,204,538	1.243 %	1 318 M p
JTC Employer Solutions Trustee Ltd. 0.7116 %	14,428,009	0.7116 %	755 M p
Wellington Trust Co., NA 0.6194 %	12,557,487	0.6194 %	657 M p
RBC Private Counsel (USA), Inc. 0.5089 %	10,318,290	0.5089 %	540 M p
Acadian Asset Management LLC 0.4421 %	8,964,159	0.4421 %	469 M p
Holocene Advisors, LP 0.4003 %	8,116,527	0.4003 %	425 M p
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	61.32%
Other	3.4%
Individuals	0.37%
State Street Corp.	0.15%
Manulife Financial Corp.	0.09%
SEI Investments Co.	0.04%
Governments	0.02%
Standard Chartered Plc	0.01%
Wärtsilä Oyj Abp	0.01%
ABC arbitrage SA	0.01%
Silvercrest Asset Management Group, Inc.	0.01%
Unknown	34.57%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	27.37%
United Kingdom	23.31%
Germany	1.89%
Norway	1.74%
Switzerland	1.71%
Canada	1.57%
France	1.02%
Italy	0.75%
Japan	0.72%
Sweden	0.71%
Netherlands	0.68%
Luxembourg	0.61%
Singapore	0.42%
Individuals	0.37%
South Korea	0.35%
Spain	0.35%
Denmark	0.3%
Australia	0.29%
Hong Kong	0.26%
Belgium	0.24%
Ireland	0.17%
Finland	0.14%
Austria	0.12%
South Africa	0.09%
Saudi Arabia	0.05%
New Zealand	0.05%
Kazakhstan	0.03%
Thailand	0.02%
Taiwan	0.02%
Puerto Rico	0.01%
Bermuda	0.01%
China	0.01%
Israel	0.01%
Liechtenstein	0.01%
Qatar	0.01%
Trinidad and Tobago	0.01%

Based on 1000 largest holdings

GSK plc is a United Kingdom-based biopharma company. The Companyâ€™s segments include Commercial Operations and Research and Development. The Company is focused on the science of the immune system and advanced technologies, investing in four core therapeutic areas-respiratory, immunology and inflammation; oncology; human immunodeficiency virus (HIV), and infectious diseases. Its specialty medicines prevent and treat diseases, from asthma, cancer and HIV to autoimmune diseases like lupus. General medicines include inhalers for asthma and chronic obstructive pulmonary disease (COPD) with antibiotics. Its portfolio also includes Efimosfermin, a fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development. The Company also engaged in ozureprubart, a long-acting anti-immunoglobulin E (IgE) monoclonal antibody. The Company also owns HS235, a potential molecule for the treatment of pulmonary hypertension (PH).

Employees

66,841

Sector

Pharmaceuticals

Calendar

05-14 - Ex-dividend date - 0.17 GBX

More about the company